Global Herd Immunity Against COVID-19 Unlikely, Says Ebola Vaccine Developer
Leverage Labor Diversity, Tech
As coronavirus variants keep emerging, global herd immunity is unlikely, says Steven Jones, one of the developers of the first Ebola vaccine. In a wide-ranging discussion with McKinsey, he and other experts weighed in on ways to live with COVID-19, which is expected to soon become endemic.
